MIRA INFORM REPORT
|
Report No. : |
334688 |
|
Report Date : |
03.08.2015 |
IDENTIFICATION DETAILS
|
Name : |
CHEMO HOLDING SL |
|
|
|
|
Registered Office : |
C/ Quintanapalla, 2 4º. - Madrid - 28050 - Madrid |
|
|
|
|
Country : |
Spain |
|
|
|
|
Financials (as on) : |
2013 |
|
|
|
|
Date of Incorporation : |
22.11.2013 |
|
|
|
|
Legal Form : |
Private Company |
|
|
|
|
Line of Business : |
Activities of holding companies [We tried to confirm / obtain the detailed activity but the same is
not available from any sources] |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
Status : |
Holding Company |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31, 2015
|
Country Name |
Previous Rating (31.12.2014) |
Current Rating (31.03.2015) |
|
Spain |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SPAIN - ECONOMIC OVERVIEW
After
experiencing a prolonged recession in the wake of the global financial crisis
that began in 2008, in 2014 Spain marked the first full year of positive economic
growth in seven years, largely due to increased private consumption. At the
onset of the global financial crisis Spain's GDP contracted by 3.7% in 2009,
ending a 16-year growth trend, and continued contracting through most of 2013.
In 2013 the government successfully shored up struggling banks - exposed to the
collapse of Spain's depressed real estate and construction sectors - and in
January 2014 completed an EU-funded restructuring and recapitalization program.
Until
2014, credit contraction in the private sector, fiscal austerity, and high
unemployment weighed on domestic consumption and investment. The unemployment
rate rose from a low of about 8% in 2007 to more than 26% in 2013, but labor
reforms prompted a modest reduction to 23.7% in 2014. High unemployment
strained Spain's public finances, as spending on social benefits increased
while tax revenues fell. Spain’s budget deficit peaked at 11.4% of GDP in 2010,
but Spain gradually reduced the deficit to just under 7% of GDP in 2013-14,
slightly above the 6.5% target negotiated between Spain and the EU. Public debt
has increased substantially – from 60.1% of GDP in 2010 to more than 97% in
2014.
Exports
were resilient throughout the economic downturn and helped to bring Spain's
current account into surplus in 2013 for the first time since 1986, where it
remained in 2014. Rising labor productivity and an internal devaluation
resulting from moderating labor costs and lower inflation have helped to
improve foreign investor interest in the economy and positive FDI flows have
been restored.
The
government's efforts to implement labor, pension, health, tax, and education
reforms - aimed at supporting investor sentiment - have become overshadowed by
political activity in 2015 in anticipation of the national parliamentary
elections in November. Spain’s 2015 budget, published in September 2014, rolls
back some recently imposed taxes in advance of the elections and leaves
untouched the country’s value-added tax (VAT) regime, which continues to
generate significantly lower revenue than the EU average. Spain’s borrowing
costs are dramatically lower since their peak in mid-2012, and despite the
recent uptic in economic activity, inflation has dropped sharply, from 1.5% in
2013 to nearly flat in 2014.
|
Source
: CIA |
EXECUTIVE
SUMMARY
|
Name: |
CHEMO HOLDING SL |
|
NIF / Fiscal code: |
B86874617 |
|
Status: |
ACTIVE |
|
Incorporation Date: |
22/11/2013 |
|
Register Data |
Register Section 8 Sheet 566584 |
|
Last Publication in
BORME: |
05/09/2014 [Miscellaneous Concepts] |
|
Last Published Account Deposit: |
2013 |
|
Share Capital: |
37.969.781 |
|
|
|
|
Localization: |
C/ QUINTANAPALLA, 2 4º. - MADRID - 28050 - MADRID |
|
Telephone - Fax - Email - Website: |
Telephone. 913 021 560 Website. www.chemogroup.com |
|
|
|
|
Activity: |
|
|
NACE: |
6420 - Activities of holding companies |
|
Registered Trademarks: |
|
|
Audited / Opinion: |
No |
|
Tenders and Awards: |
|
|
Subsidies: |
0 for a total cost of 0 |
|
Quality Certificate: |
No |
|
|
|
|
Prospects: |
Consolidation |
|
Industry situation: |
Maturity |
Defaults,
Legal Claims and Insolvency Proceedings :
|
|
|
Number |
Amount (€) |
Most Recent Entry |
|
Insolvency Proceedings, Bankruptcy and Suspension of Payments |
|
Unpublished |
--- |
--- |
|
Defaults on debt with Financial Institutions and Large Companies |
|
None |
--- |
--- |
|
Judicial Claims (Notices, Executive Proceedings, Attachments,
Auctions, Bad Debt) |
|
None |
0 |
--- |
|
Proceedings heard by the Civil Court |
|
Unpublished |
0 |
--- |
|
Proceedings heard by the Labour Court |
|
Unpublished |
0 |
--- |
|
Partners: |
|
|
|
CHEMO ESPAÑA SL |
100 % |
|
|
Shares: |
7 |
|
|
Other Links: |
1 |
|
|
No. of Active Corporate Bodies: |
|
|
|
|
|
|
Guarantees: |
|
|
Properties Registered: |
Company NO, Administrator NO |
|
Financing / Guarantee Sources : |
Sources NO, Guarantees NO |
|
|
|
|
|
|
|
INVESTIGATION SUMMARY |
|
|
A leading company of a Group of a pharmaceutical sector that offers
pharmaceutical solutions with added values (in Industrial, which is an own
trademark and biotechnical) to the medicine in more than 40 countries. A
percentage of 99,99 % of its assets are represented through the
participations in companies that belong to the Group. |
|
|
Enquiry Details |
|
|
Business address regime: |
Rent |
Identification
|
Social Denomination: |
CHEMO HOLDING
SL |
|
NIF / Fiscal code: |
B86874617 |
|
Corporate Status: |
ACTIVE |
|
Start of activity: |
2014 |
|
Registered Office: |
C/
QUINTANAPALLA, 2 4º. |
|
Locality: |
MADRID |
|
Province: |
MADRID |
|
Postal Code: |
28050 |
|
Telephone: |
913 021 560 |
|
Website: |
www.chemogroup.com |
Branch Offices
Activity
|
NACE: |
6420 |
|
Legal
Form: |
PURCHASE, POSSESSION, BENEFIT, ADMINISTRATION, MANAGEMENT
OF VALUES AND ACTIONS OF CORPORATIONS OR SPANISH OR INTERNATIONAL ENTITIES,
WITH THEIR RESIDENCE IN SPAIN OR OUT OF SPAIN, AND WHOM HAVE THE POSSIBILITY
TO MAKE INVESTMENT, HELD ON ITS OWN ACCOUNT. |
|
Additional
Information: |
A leading company of a Group of a pharmaceutical sector
that offers pharmaceutical solutions with added values (in Industrial, which
is an own trademark and biotechnical) to the medicine in more than 40
countries. As a family and holding company, no incomes associated to
commercial activities were registered. It takes part in many different
corporations like QUIMICA SINTETICA SA, CHEMO IBERICA, SA, LABORATORIOS
LICONSA SA y LABORATORIOS LEON FARMA, SA among others. |
|
Additional
Address: |
- C/ QUINTANAPALLA, 2 4º, 28050-MADRID, where its
registered offoce and central offices are located in rent. |
|
Import
/ export: |
DOES NOT IMPORT / DOES NOT EXPORT |
|
Future
Perspective: |
Consolidation |
|
Industry
situation: |
Maturity |
Chronological
Summary
|
Year |
Act |
|
2013 |
Appointments/
Re-elections (4) Company Formation (1) Declaration of Sole Propietorship (1) |
|
2014 |
Accounts deposit (year
2013) Appointments/ Re-elections (3) Cessations/ Resignations/ Reversals (2)
Increase of Capital (2) Other Concepts/ Events (1) |
Breakdown
of Owners' Equity
|
Registered
Capital: |
37.969.781 |
|
Paid up capital: |
37.969.781 |
Updated
Evolution of the Subscribed and Paid-in Capital
|
|
|
Publishing Date |
Registration Type |
Capital Subscribed |
Paid up capital |
Underwritten result |
Disbursed Result |
|
27/12/2013 |
Company Formation |
3.000 |
3.000 |
3.000 |
3.000 |
|
25/02/2014 |
Increase of
Capital |
37.665.775 |
37.665.775 |
37.668.775 |
37.668.775 |
|
14/03/2014 |
Increase of
Capital |
301.006 |
301.006 |
37.969.781 |
37.969.781 |
Active
Social Bodies
|
Post published |
Social Body's Name |
Appointment Date |
Other Positions in this Company |
|
SINGLE PARTNER |
CHEMO ESPAÑA SL |
27/12/2013 |
1 |
|
JOINT
ADMINISTRATOR |
MARTIN MORAN MARIA
SANDRA |
28/08/2014 |
1 |
|
|
PONCE GUTIERREZ
IGNACIO |
28/08/2014 |
4 |
|
|
PELIZZARI GUSTAVO
DANIEL LORENZO |
28/08/2014 |
5 |
|
COMBINED PROXY |
PELIZZARI GUSTAVO
DANIEL LORENZO |
27/12/2013 |
5 |
|
|
PONCE GUTIERREZ
IGNACIO |
27/12/2013 |
4 |
|
JOINT
ATTORNEY/COMBINED PROXY |
ROMERO CAMACHO
SILOS CARLOS |
27/12/2013 |
1 |
|
|
QUIJANO RIESTRA
ALVARO |
27/12/2013 |
1 |
|
|
NOBLEJAS SANCHEZ
GIL ANTONIO |
27/12/2013 |
1 |
|
|
SECO DE HERRERA
BENITEZ CARLOS ALBERTO |
27/12/2013 |
1 |
|
|
BARRO MANUEL
IGNACIO |
27/12/2013 |
1 |
|
|
GUTIERREZ FLOREZ
ELISA-ISABEL |
27/12/2013 |
1 |
|
PROXY |
MARTIN MORAN
SANDRA MARIA |
08/08/2014 |
1 |
|
|
GARCIA MARINA
LAURA |
08/08/2014 |
2 |
|
|
GARCIA PICAZO
ANDRES |
27/12/2013 |
1 |
Historical
Social Bodies
|
Social Body's Name |
Post published |
End Date |
Other Positions in this Company |
|
ALCALDE GIRAUDO
ISABEL |
MEMBER OF THE
BOARD |
28/08/2014 |
4 |
|
|
SECRETARY |
28/08/2014 |
|
|
|
JOINT
ATTORNEY/COMBINED PROXY |
27/12/2013 |
|
|
|
JOINT
ATTORNEY/COMBINED PROXY |
08/08/2014 |
|
|
GARCIA MARINA
LAURA |
PROXY |
08/08/2014 |
2 |
|
PELIZZARI GUSTAVO
DANIEL LORENZO |
MEMBER OF THE
BOARD |
28/08/2014 |
5 |
|
|
PRESIDENT |
28/08/2014 |
|
|
|
JOINT
ATTORNEY/COMBINED PROXY |
27/12/2013 |
|
|
PONCE GUTIERREZ
IGNACIO |
MEMBER OF THE
BOARD |
28/08/2014 |
4 |
|
|
JOINT
ATTORNEY/COMBINED PROXY |
27/12/2013 |
|
Executive
board
|
Post |
NIF |
Name |
|
ADMINISTRATOR |
|
GUSTAVO DANIEL LORENZO
PELIZZARI |
|
ADMINISTRATOR |
|
IGNACIO PONCE
GUTIERREZ |
|
ADMINISTRATOR |
|
MARIA SANDRA
MARTIN MORAN |
Defaults,
Legal Claims and Insolvency Proceedings
Section enabling assessment
of the degree of compliance of the company queried with its payment
obligations. It provides information on the existence and nature of all stages
of Insolvency and Legal Proceedings published with reference to the Company in
the country's various Official Bulletins and national newspapers, as well
Defaults Registered in the main national credit bureaus (ASNEF Industrial and
RAI ).
> Summary
Chronological summary
|
|
|
Number of Publications |
Amount (_) |
Start date |
End date |
|
Insolvency Proceedings,
Bankruptcy and Suspension of Payments |
|
Unpublished |
--- |
--- |
--- |
|
Request/Declaration |
|
0 |
--- |
date |
|
|
Proceedings |
|
--- |
--- |
|
--- |
|
Resolution |
|
--- |
--- |
|
--- |
|
Defaults on debt with
Financial Institutions and Large Companies |
Bank and Commercial
Delinquency |
None |
0 |
|
|
|
Status: Friendly |
|
--- |
|
|
|
|
Status: Pre-Litigation |
|
--- |
|
|
|
|
Status: Litigation |
|
--- |
|
|
|
|
Status: Non-performing |
|
--- |
|
|
|
|
Status: insolvency
proceedings, bankruptcy and suspension of payments |
|
--- |
|
|
|
|
Other status |
|
--- |
|
|
|
|
Legal and Administrative
Proceedings |
|
Unpublished |
--- |
|
|
|
Notices of defaults and
enforcement |
|
--- |
--- |
|
--- |
|
Seizures |
|
--- |
--- |
|
--- |
|
Auctions |
|
--- |
--- |
|
--- |
|
Declarations of insolvency and
bad debt |
|
--- |
--- |
|
--- |
|
Proceedings heard by the Civil
Court |
|
Unpublished |
--- |
|
|
|
Proceedings heard by the
Labour Court |
|
Unpublished |
--- |
|
|
> Details
|
Positive Factors |
Adverse Factors |
Result of query submitted to the R.A.I. (Spanish Bad Debt Register) on
LEGAL
CLAIMS
Summary
of Judicial Claims
|
|
|
|
|
|
|
|
||
|
|
|
No se han
publicado |
|
|
|
|
No se han
publicado |
|
|
|
|
||
|
|
|
No se han
publicado |
|
|
|
|
No se han
publicado |
|
|
|
|
No se han
publicado |
|
|
|
|
No se han
publicado |
|
|
|
|
||
|
|
|
No se han
publicado |
|
|
|
|
No se han
publicado |
|
|
|
|
||
|
|
|
No se han
publicado |
|
Guarantees
References
Link List
|
IS RELATED WITH: |
1 Entities |
|
PARTICIPATES IN: |
7 Entities |
|
SHAREHOLDERS: |
1 Entities |
> Shareholders
|
Relationship |
Entity |
Province |
Shareholding stake |
|
SHAREHOLDERS |
CHEMO ESPAÑA SL |
MADRID |
100 |
|
|
LABORATORIOS LICONSA SA |
BARCELONA |
100 |
|
|
LABORATORIOS LEON FARMA SA |
LEON |
100 |
|
|
LABORATORIOS FARMALAN SA |
LEON |
100 |
|
|
CHEMO RESEARCH SL |
MADRID |
100 |
|
PARTICIPATES IN |
CHEMO IBERICA SA |
BARCELONA |
100 |
|
|
QUIMICA SINTETICA SA |
BARCELONA |
100 |
|
|
VETPHARMA ANIMAL HEALTH S.L |
BARCELONA |
100 |
> Other relationships
|
Relationship |
Entity |
Province |
Shareholding stake |
|
IS RELATED WITH |
KEVILMARE ESPAÑA SL |
MADRID |
|
Turnover
|
Total Sales 2014 |
0 |
The sales data is from the latest available financial
statements. Failing that, are estimates data calculated by statistical methods.
Financial
Accounts and Balance Sheets
Financial Years Presented
|
Ejercicio |
Tipo de Cuentas Anuales |
Fecha Presentacion |
|
2013 |
Normales |
December 2014 |
The data in the report regarding the last Company Accounts
submitted by the company is taken from the TRADE REGISTER serving the region in
which the company's address is located 31/12/2013
> Balance en formato
Abreviado de acuerdo al Nuevo Plan General Contable 2007
Information corresponding to the fiscal year 2013 is taken
from information submitted to the TRADE REGISTER. Data corresponding to fiscal
years before 2013 has been compiled based on the equivalence criteria
stipulated in Act JUS/206/2009. Where the provisions of the Act did not
establish relevant equivalence criteria. To view details on the methodology.
|
|
ORIGINAL |
|
Assets |
2013 |
|
A) NON-CURRENT ASSETS:
11000 |
188.328.875,00 |
|
I.
Intangible fixed assets : 11100 |
0,00 |
|
II.
Tangible fixed assets : 11200 |
0,00 |
|
III. Real
estate investment: 11300 |
0,00 |
|
IV.
Long-term investments in Group companies and associates : 11400 |
188.328.875,00 |
|
V.
Long-term financial investments: 11500 |
0,00 |
|
VI.
Assets for deferred tax : 11600 |
0,00 |
|
VII.
Non-current trade debtors : 11700 |
0,00 |
|
B) CURRENT ASSETS: 12000 |
9.560,00 |
|
I. Non-current
assets held for sale : 12100 |
0,00 |
|
II.
Stocks: 12200 |
0,00 |
|
III.
Trade debtors and others receivable accounts: 12300 |
6.560,00 |
|
1.- Customers for sales and provisions of services :
12380 |
0,00 |
|
a) Long-term receivables from sales and
services supplied : 12381 |
0,00 |
|
b) Customers for sales and provisions of
services : 12382 |
0,00 |
|
2.- Called up share capital : 12370 |
0,00 |
|
3.- Other accounts receivable : 12390 |
6.560,00 |
|
IV.
Short-term investments in Group companies and associates: 12400 |
0,00 |
|
V.
Short-term financial investments : 12500 |
0,00 |
|
VI.
Short-term accruals: 12600 |
0,00 |
|
VII. Cash
and other equivalent liquid assets : 12700 |
3.000,00 |
|
TOTAL ASSETS (A + B) :
10000 |
188.338.435,00 |
|
|
ORIGINAL |
|
Liabilities and Net
Worth |
2013 |
|
A) NET WORTH: 20000 |
188.316.567,00 |
|
A1)
Shareholders' equity : 21000 |
188.316.567,00 |
|
I. Capital: 21100 |
37.668.775,00 |
|
1.- Registered capital: 21110 |
37.668.775,00 |
|
2.- (Uncalled capital) : 21120 |
0,00 |
|
II. Share premium: 21200 |
150.663.100,00 |
|
III. Reserves: 21300 |
0,00 |
|
IV. (Common stock equity): 21400 |
0,00 |
|
V. Profit or loss brought forward: 21500 |
0,00 |
|
VI. Other shareholders' contributions: 21600 |
0,00 |
|
VII. Result of the period: 21700 |
-15.308,00 |
|
VIII. (Interim dividend): 21800 |
0,00 |
|
IX. Other net worth instruments: 21900 |
0,00 |
|
A-2) Adjustments
due to changes in value: 22000 |
0,00 |
|
A-3)
Received subsidies, donations and legacies: 23000 |
0,00 |
|
B) NON-CURRENT LIABILITIES:
31000 |
0,00 |
|
I.
Long-term provisions: 31100 |
0,00 |
|
II. Long-term
creditors : 31200 |
0,00 |
|
1.- Amounts owed to credit institutions: 31220 |
0,00 |
|
2.- Creditors from financial leasing : 31230 |
0,00 |
|
3.- Other long-term creditors : 31290 |
0,00 |
|
III.
Long-term debts with Group companies and associates: 31300 |
0,00 |
|
IV.
Liabilities for deferred tax: 31400 |
0,00 |
|
V.
Long-term accruals: 31500 |
0,00 |
|
VI.
Non-current trade creditors : 31600 |
0,00 |
|
VII. Special
long-term debts : 31700 |
0,00 |
|
C) CURRENT LIABILITIES :
32000 |
21.868,00 |
|
I.
Liabilities linked to non-current assets held for sale : 32100 |
0,00 |
|
II.
Short-term provisions: 32200 |
0,00 |
|
III. Short-term
creditors : 32300 |
0,00 |
|
1.- Amounts owed to credit institutions: 32320 |
0,00 |
|
2.- Creditors from financial leasing : 32330 |
0,00 |
|
3.- Other short-term creditors : 32390 |
0,00 |
|
IV.
Short-term debts with Group companies and associates: 32400 |
0,00 |
|
V. Trade
creditors and other accounts payable: 32500 |
21.868,00 |
|
1.- Suppliers: 32580 |
18.079,00 |
|
a) Long-term debts : 32581 |
0,00 |
|
b) Short-term debts : 32582 |
18.079,00 |
|
2.- Other creditors : 32590 |
3.789,00 |
|
VI.
Short-term accruals: 32600 |
0,00 |
|
VII.
Special short-term debts : 32700 |
0,00 |
|
TOTAL NET WORTH AND
LIABILITIES (A + B + C) : 30000 |
188.338.435,00 |
|
Profit and Loss |
2013 |
|
1. Net
turnover: 40100 |
0,00 |
|
2.
Changes in stocks of finished goods and work in progress: 40200 |
0,00 |
|
3. Works carried
out by the company for its assets: 40300 |
0,00 |
|
4.
Supplies : 40400 |
0,00 |
|
5. Other
operating income: 40500 |
0,00 |
|
6.
Personnel costs: 40600 |
0,00 |
|
7. Other
operating costs: 40700 |
-21.868,00 |
|
8.
Amortisation of fixed assets: 40800 |
0,00 |
|
9.
Allocation of subsidies of non-financial fixed assets and other: 40900 |
0,00 |
|
10.
Excess provisions : 41000 |
0,00 |
|
11. Impairment
and result of transfers of fixed assets: 41100 |
0,00 |
|
12.
Negative difference in combined businesses: 41200 |
0,00 |
|
13. Other
results : 41300 |
0,00 |
|
A) OPERATING INCOME (1 + 2 + 3
+ 4 + 5 + 6 + 7 + 8 + 9 + 10 + 11 + 12 + 13) : 49100 |
-21.868,00 |
|
14.
Financial income : 41400 |
0,00 |
|
a) Allocation of financial subsidies, donations and legacies:
41430 |
0,00 |
|
b) Other financial income: 41490 |
0,00 |
|
15.
Financial expenditure: 41500 |
0,00 |
|
16.
Changes in fair value of financial instruments : 41600 |
0,00 |
|
17.
Exchange rate differences : 41700 |
0,00 |
|
18. Impairment
and result for transfers of financial instruments: 41800 |
0,00 |
|
19. Other
financial income and expenditure: 42100 |
0,00 |
|
a) Incorporation of financial expenditure to assets:
42110 |
0,00 |
|
b) Financial income from arrangement with creditors:
42120 |
0,00 |
|
c) Other income and expenditure: 42130 |
0,00 |
|
B) FINANCIAL REVENUE (14 + 15
+ 16 + 17 + 18 + 19) : 49200 |
0,00 |
|
C) NET RESULT BEFORE TAXES (A
+ B) : 49300 |
-21.868,00 |
|
20.
Income taxes: 41900 |
6.560,00 |
|
D) RESULT OF THE PERIOD (C +
20) : 49500 |
-15.308,00 |
CASHFLOW
STATEMENT
Model: Normal
> Source of information: Data
contained in this section is taken from the information declared in the Annual
Accounts submitted to the Trade Register.
|
|
2013 |
|
1. Fiscal year result before
taxes.: 61100 |
-21.868,00 |
|
2. Results adjustments.:
61200 |
0,00 |
|
3. Changes in current capital
equity.: 61300 |
21.868,00 |
|
d)
Debtors and other accounts receivable (+/-). : 61302 |
-6.560,00 |
|
d)
Creditors and other accounts payable (+/-). : 61304 |
28.428,00 |
|
4. Other cash flows for operating
activities.: 61400 |
0,00 |
|
5. Operating activity cash
flows (1 + 2 + 3 + 4) : 61500 |
0,00 |
|
6. Payments for investment
(-).: 62100 |
-188.328.875,00 |
|
a)
Companies of the group and affiliates. : 62101 |
-188.328.875,00 |
|
7. Divestment payment
collection (+). : 62200 |
0,00 |
|
8. Investment activity cash
flows (6 + 7) minus Amortization: 62300 |
-188.328.875,00 |
|
9. Payment collection and
payments for equity instruments. : 63100 |
188.331.875,00 |
|
a) Issuance
of equity instruments (+). : 63101 |
188.331.875,00 |
|
10. Payment collection and
payments for financial liabilities instruments.: 63200 |
0,00 |
|
11. Payments from dividends
and remunerations from other assets instruments. : 63300 |
0,00 |
|
12. Cash flows for financing
activities (9+10+11).: 63400 |
188.331.875,00 |
|
D) EFFECT OF EXCHANGE RATE
CHANGES: 64000 |
0,00 |
|
E) NET INCREASE/DECREASE OF
CASH OR EQUIVALENT ASSETS (+/-5+/-8+/12+/-D) : 65000 |
3.000,00 |
|
Cash or equivalent
assets as of end of the fiscal year.: 65200 |
3.000,00 |
FINANCIAL
DIAGNOSIS
> Economic-Financial
Comparative Analysis
Data used in the
following ratios and indicators is taken from the Annual Accounts submitted by
the company to the TRADE REGISTER.
> Comparison within the
Sector
|
Cash Flow |
2013 |
Variación 2013 - |
|
||
|
|
Empresa |
Sector |
Empresa |
Sector |
|
|
Cash Flow over Sales: |
|
0,02
% |
NaN
% |
NaN
% |
|
|
EBITDA over Sales: |
|
-1,51
% |
NaN
% |
NaN
% |
|
|
Cash Flow Yield: |
0,00
% |
0,00
% |
NaN
% |
NaN
% |
|
|
Profitability |
2013 |
Variación 2013 - |
|
||
|
|
Empresa |
Sector |
Empresa |
Sector |
|
|
Operating economic
profitability: |
-228,74
% |
-12,54
% |
NaN
% |
NaN
% |
|
|
Total economic profitability:
|
-0,01
% |
-3,42
% |
NaN
% |
NaN
% |
|
|
Financial profitability:
|
-0,01
% |
-12,05
% |
NaN
% |
NaN
% |
|
|
Margin: |
|
-25,04
% |
NaN
% |
NaN
% |
|
|
Mark-up: |
|
-22,14
% |
NaN
% |
NaN
% |
|
|
Solvency |
2013 |
Variación 2013 - |
|
||
|
|
Empresa |
Sector |
Empresa |
Sector |
|
|
Liquidity: |
0,14 |
0,16 |
NaN |
NaN |
|
|
Acid Test: |
0,44 |
1,22 |
NaN |
NaN |
|
|
Working Capital / Investment:
|
0,00 |
0,08 |
NaN |
NaN |
|
|
Solvency: |
0,44 |
1,70 |
NaN |
NaN |
|
|
Indebtedness |
2013 |
Variación 2013 - |
|
||
|
|
Empresa |
Sector |
Empresa |
Sector |
|
|
Indebtedness level: |
0,00 |
1,06 |
NaN |
NaN |
|
|
Borrowing Composition: |
0,00 |
0,96 |
NaN |
NaN |
|
|
Repayment Ability: |
7,29 |
131,86 |
NaN |
NaN |
|
|
Warranty: |
8.612,52 |
2,11 |
NaN |
NaN |
|
|
Generated resources / Total
creditors: |
-0,70 |
-0,06 |
NaN |
NaN |
|
|
Efficiency |
2013 |
Variación 2013 - |
|
||
|
|
Empresa |
Sector |
Empresa |
Sector |
|
|
Productivity: |
|
0,94 |
NaN |
NaN |
|
|
Turnover of Collection Rights
: |
0,00 |
2,93 |
NaN |
NaN |
|
|
Turnover of Payment Entitlements:
|
1,00 |
2,36 |
NaN |
NaN |
|
|
Stock rotation: |
|
2,56 |
NaN |
NaN |
|
|
Assets turnover: |
0,00 |
0,50 |
NaN |
NaN |
|
|
Borrowing Cost: |
0,00 |
3,38 |
NaN |
NaN |
|
> Trend of indicators under the
General Accounting Plan of 2007 (2013)
|
Cash Flow |
2013 |
|
|
Cash Flow Yield: |
0,00
% |
|
|
Profitability |
2013 |
|
|
Operating economic
profitability: |
-228,74
% |
|
|
Total economic profitability:
|
-0,01
% |
|
|
Financial profitability:
|
-0,01
% |
|
|
Solvency |
2013 |
|
|
Liquidity: |
0,14 |
|
|
Acid Test: |
0,44 |
|
|
Working Capital / Investment:
|
0,00 |
|
|
Solvency: |
0,44 |
|
|
Indebtedness |
2013 |
|
|
Indebtedness level: |
0,00 |
|
|
Borrowing Composition: |
0,00 |
|
|
Repayment Ability: |
7,29 |
|
|
Warranty: |
8.612,52 |
|
|
Generated resources / Total
creditors: |
-0,70 |
|
|
Efficiency |
2013 |
|
|
Turnover of Collection Rights
: |
0,00 |
|
|
Turnover of Payment
Entitlements: |
1,00 |
|
|
Assets turnover: |
0,00 |
|
|
Borrowing Cost: |
0,00 |
|
COMPARATIVE
SECTORIAL BALANCE
Sector-based Comparison under the rules of the New General
Accounting Plan.
|
|
Variación
- |
|
|
|
Empresa |
Sector |
|
|
Variación
- |
|
|
|
Empresa |
Sector |
|
|
Variación
- |
|
|
|
Empresa |
Sector |
News
-
Public
Tenders and Works Won
No Public Tenders assigned to the name of the company.
Research
Summary
|
A leading
company of a Group of a pharmaceutical sector that offers pharmaceutical
solutions with added values (in Industrial, which is an own trademark and
biotechnical) to the medicine in more than 40 countries. A percentage of
99,99 % of its assets are represented through the participations in companies
that belong to the Group. |
Answer
to additional question
The owner of the holding company
participates in the Group CHEMOS Societies.
Sources
|
Registry of
Commerce's Official Gazette. Own and external data bases Company References |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.64.01 |
|
UK Pound |
1 |
Rs.99.84 |
|
Euro |
1 |
Rs.70.96 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
TRU |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.